Search

Hutchison China MediTech Ltd ADR

Open

SectorHealthcare

11.95 -1.32

Overview

Share price change

24h

Current

Min

11.51

Max

12.16

Key metrics

By Trading Economics

Income

-8.9M

-8M

Sales

3.7M

139M

P/E

Sector Avg

121.8

57.366

Profit margin

-5.724

Employees

1,790

EBITDA

18M

4M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+23.76% upside

Market Stats

By TradingEconomics

Market Cap

205M

2.1B

Previous open

13.27

Previous close

11.95

News Sentiment

By Acuity

100%

0%

327 / 340 Ranking in Healthcare

Hutchison China MediTech Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

31 sie 2026, 23:56 UTC

News

Array Technologies has acquired Affordable Wire Management, enhancing its portfolio and growth potential. Shares are trading slightly higher in after-market hours.

31 sie 2026, 23:56 UTC

News

Frontier Group Holdings plans to terminate leases for 13 A320neo aircraft, leading to anticipated charges of $60 million to $80 million. Shares are lower in after-market hours.

31 sie 2026, 23:51 UTC

News

Howmet Aerospace shares are higher in after-market hours following Elon Musk's comments on SpaceX's gas turbine blade plans, sparking renewed interest and improved sentiment.

31 sie 2026, 23:46 UTC

News

American Water Works shares are trading higher in after-market hours amid a pending merger settlement approval from the Pennsylvania Public Utility Commission.

31 sie 2026, 23:46 UTC

Correlated Moves
News

Renasant Corp appointed Catherine Mealor as Executive Vice President, effective October 2026. Shares are trading higher in after-market hours following the announcement.

31 sie 2026, 23:46 UTC

News

IQVIA Holdings Inc shares are higher in after-market trading, remaining above their 20-day moving average amid sector growth expectations despite ongoing challenges.

31 sie 2026, 23:41 UTC

News

Quantum Corp shares declined in after-market trading amid broader market sentiment affected by hawkish comments from Federal Reserve Chair Kevin Warsh on inflation.

31 sie 2026, 23:41 UTC

Event
News

Jazz Pharmaceuticals PLC reported positive results from the HERIZON-GEA-01 trial for Ziihera, leading shares higher in after-hours trading.

31 sie 2026, 23:41 UTC

News

KeyCorp shares are higher in after-market hours following the appointment of Chris Doll as Chief Strategy Officer, effective August 31, 2026.

31 sie 2026, 23:16 UTC

News

Delek US Holdings Inc. supports Small Refinery Exemptions, enabling increased investments in refineries and U.S. energy infrastructure. Shares are higher in after-market trading.

31 sie 2026, 23:16 UTC

News

Sylvamo Corp shares are higher in after-market hours, buoyed by strong institutional ownership and earnings per share of $1.88.

31 sie 2026, 23:11 UTC

Social Media
News

Coinbase Global shares are lower in after-market trading, amid ongoing interest and developments in the crypto space, including Webull's new services in Canada.

31 sie 2026, 23:11 UTC

News

Under Armour has filed for a mixed shelf offering, including potential debt and equity. Shares traded roughly flat during after-market hours.

31 sie 2026, 23:11 UTC

News

Northrop Grumman secured an $86.1 million contract extension from the U.S. Department of War, boosting shares higher in after-market trading.

31 sie 2026, 23:11 UTC

Correlated Moves
News

The USD/PLN is lower today, influenced by comments from Federal Reserve Chair Kevin Warsh regarding potential interest rate hikes amid rising inflation concerns.

31 sie 2026, 23:06 UTC

News

Oracle Corp is higher in after-market trading, despite challenges including a record low free cash flow yield and concerns about its hyperscaler strategy.

31 sie 2026, 23:06 UTC

News

Ares Capital Corp raised ¥612 billion for its Japan Logistics Development Partners V LP, exceeding its predecessor's size. Shares are higher in after-market hours.

31 sie 2026, 23:06 UTC

Social Media
News

KKR & Co Inc. shares are higher in after-market hours following the firm's support for Wella Co's upcoming IPO on the New York Stock Exchange.

31 sie 2026, 23:06 UTC

News

RTX Corp partners with Lockheed Martin and Tata Advanced Systems for Javelin missile co-production in India. Shares are higher in after-market trading.

31 sie 2026, 23:06 UTC

Event
News

Eli Lilly shares are higher in after-market trading following regulatory clearance for its merger with AtaiBeckley, marking a key milestone in the process.

31 sie 2026, 23:06 UTC

News

Johnson & Johnson shares are higher in after-market trading following the announcement of an investor conference call on October 13, 2026, for third-quarter results.

31 sie 2026, 23:06 UTC

Correlated Moves
News

The USD/NOK is trading lower, reflecting a decline since Friday. Market sentiment shifts after comments from Federal Reserve Chair Kevin Warsh on inflation and interest rates.

31 sie 2026, 23:06 UTC

News
Correlated Moves

Geopolitical tensions and hawkish Fed remarks are supporting gains in CAD/HKD, which is trading near the upper end of its one-month range.

31 sie 2026, 23:06 UTC

Correlated Moves
News

The USD/SGD is lower today, influenced by Federal Reserve comments on inflation and rising Treasury yields. The pair remains near its one-month range's lower end.

31 sie 2026, 23:01 UTC

News

Global Water Resources Inc shares lower after announcing a $0.03 dividend, with analysts projecting earnings of $0.13 per share next year.

31 sie 2026, 23:01 UTC

News

Align Technology shares are lower in after-market trading following the appointment of Quentin Blackford to its Board of Directors, effective immediately.

31 sie 2026, 23:01 UTC

News

elf Beauty Inc shares are lower in after-market trading amid broader market unease following hawkish comments from Federal Reserve Chair Kevin Warsh.

31 sie 2026, 23:01 UTC

News

Charter Communications shares are lower in after-market hours following the announcement of CFO Jessica Fischer's resignation effective October 15, 2026.

31 sie 2026, 23:01 UTC

News

Avista Corp seeks to reduce natural gas rates by about 11.5%, potentially lowering bills by $7.38. Shares advanced in after-market trading.

31 sie 2026, 23:01 UTC

Social Media
News

Evercore upgraded Duolingo to Outperform, raising its price target to $210. Shares rose after market close, reflecting positive sentiment around the stock.

Peer Comparison

Price change

Hutchison China MediTech Ltd ADR Forecast

Price Target

By TipRanks

23.76% upside

12 Months Forecast

Average 15 USD  23.76%

High 16 USD

Low 14 USD

Based on 2 Wall Street analysts offering 12 month price targets forHutchison China MediTech Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat